Alzheimer's disease (AD) is the most common cause of neurodegenerative dementia, whilst
Parkinson's disease (PD) is a neurodegenerative movement disorder. These two …

More than 5 years have passed since the Diffusion Tensor Image Analysis ALong the
Perivascular Space (DTI-ALPS) method was proposed with the intention of evaluating the …

Background Brain glymphatic dysfunction may contribute to the development of α-
synucleinopathies. Yet, noninvasive imaging and quantification remain lacking. Purpose To …

Background Glymphatic dysfunction is a crucial pathway for dementia. Alzheimer's disease
(AD) pathologies co-existing with cerebral small vessel disease (CSVD) is the most common …

The clearance function is essential for maintaining brain tissue homeostasis, and the
glymphatic system is the main pathway for removing brain interstitial solutes. Aquaporin-4 …

Introduction The glymphatic system offers a perivascular pathway for the clearance of
pathological proteins and metabolites to optimize neurological functions. Glymphatic …

Background Studies of glymphatic dysfunction in Parkinson's disease (PD) patients have
attracted much attention in recent years. However, the relationships between glymphatic …

Objective Emerging pathological evidence suggests that there is an association between
glymphatic dysfunction and the progression of Parkinson's disease (PD). However, the …

Background The glymphatic system is reportedly involved in Parkinson's disease (PD).
Based on previous studies, we aimed to confirm the correlation between the glymphatic …

Background The glymphatic clearance pathway is a waste clearance system that allows for
removal of soluble proteins such as amyloid β (Aβ) from the brain. Higher Aβ levels are …